AQP4 and Alzheimer disease: Knowing that there is an overlap between anti-NMDARE and demyelinating disease (AQP4-NMOSD and MOG-AD) is important as patients may present clinically with concurrent or separate episodes of demyelination and/or atypical psychomotor features.